178 filings
Page 5 of 9
8-K
p8v ife3j24n4vfg
27 Nov 19
Aravive Announces Proposed Public Offering of Common Stock
4:15pm
8-K
e0sk49tbprw29ibf4c
20 Nov 19
Other Events
7:05am
8-K
6s9g01tjq6wl4mx2aqvs
8 Nov 19
CORRECTION – Aravive Reports Third Quarter 2019 Financial Results and Provides Recent Corporate Updates
2:33pm
8-K
kyecddtf rf0d70aj1u
7 Nov 19
Aravive Reports Third Quarter 2019 Financial Results and Provides Recent Corporate Updates
4:10pm
8-K
lbk5xh2
3 Oct 19
Other Events
7:15am
8-K
d884ff0aoicuk7
27 Sep 19
Other Events
10:15am
8-K
x8pum0h 7t9fefzb2gg
13 Sep 19
Departure of Directors or Certain Officers
4:05pm
8-K
5jkm8n5 u7oh
12 Aug 19
Other Events
7:05am
8-K
quiflyifndf
8 Aug 19
Aravive Announces Executive Management Transition Plan
5:06pm
8-K
syyratma8da2c
7 Aug 19
Aravive Reports Second Quarter 2019 Financial Results and Provides Recent Corporate Updates
4:10pm
8-K
qizzj
31 Jul 19
Aravive Reports Preliminary Results ofAVB-500 from the First Cohort of the Phase 1b/Phase 2 Recurrent Platinum Resistant Ovarian Cancer Trial
7:15am
8-K
nxiho wns
11 Jul 19
Shareholder Nominations Pursuant to Exchange Act Rule 14a-11
7:32am
8-K
uf5t ad3gyw41yx76pab
8 Jul 19
Other Events
7:16am
8-K
t77jioue3
31 May 19
Termination of a Material Definitive Agreement
4:16pm
8-K
4njzu
8 May 19
Aravive Reports First Quarter 2019 Financial Results and Provides Recent Corporate Updates
4:15pm
8-K
q1lyug
11 Apr 19
Departure of Directors or Certain Officers
4:29pm
8-K
b5sythe6 oz57tg
26 Mar 19
Entry into a Material Definitive Agreement
6:07am
8-K
svl w17yoqisaq
7 Mar 19
Results of Operations and Financial Condition
4:16pm
8-K
rer80gps4fgu26b9xf
6 Mar 19
Departure of Directors or Certain Officers
6:05am
8-K
d7ngsvr7e
12 Feb 19
Departure of Directors or Certain Officers
4:20pm